160
Views
2
CrossRef citations to date
0
Altmetric
Review

Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures

, , &
Pages 217-228 | Published online: 12 Feb 2015

References

  • United Nations World Tourism Organization (UNWTO)UNWTO Tourism Highlights 201420142 Available from: http://mkt.unwto.org/publication/unwto-tourism-highlights-2014-editionAccessed October 1, 2014
  • RosenJTravel medicine and the solid-organ transplant recipientInfect Dis Clin North Am201327242945723714348
  • BaatenGGGeskusRRKintJARoukenAHSonderGJvan den HoekASymptoms of infectious diseases in immunocompromised travelers: a prospective study with matched controlsJ Travel Med201118531832621896095
  • BoggildAKSanoMHumarASalitIGilmanMKainKCTravel patterns and risk behavior in solid organ transplant recipientsJ Travel Med2004111374314769286
  • Centers for Disease Control and Prevention (CDC)CDC Health Information for International Travel 2014New YorkOxford University Press2014
  • AsklingHDalmVThe medically immunocompromised adult traveler and pre-travel counseling: status quo 2014Travel Med Infect Dis201412321922824821082
  • van der VeldenAMClaessenAMvan Velzen-BladHVaccination responses and lymphocyte subsets after autologous stem cell transplantationVaccine200725518512851717996989
  • ElkayamOCaspiDReitblattTCharboneauDRubinsJBThe effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitisSemin Arthritis Rheum200433428328814978666
  • RosenauJHoomanNRifaiKHepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune responseTranspl Int2006191082883316961775
  • Centers for Disease Control and Prevention (CDC)Yellow fever vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep201059712120075837
  • DomingoCNiedrigMSafety of 17D derived yellow fever vaccinesExpert Opin Drug Saf20098221122119309249
  • VeitONiedrigMChapuis-TaillardCSwiss HIV Cohort StudyImmunogenicity and safety of yellow fever vaccination for 102 HIV-infected patientsClin Infect Dis200948565966619191654
  • PacanowskiJLacombeKCampaPPlasma HIV-RNA is the key determinant of long-term antibody persistence after yellow fever immunization in a cohort of 364 HIV-infected patientsJ Acquir Immune Defic Syndr201259436036722267015
  • RubinLGLevinMJLjungmanPInfectious Diseases Society of America2013 IDSA clinical practice guideline for vaccination of the immunocompromised hostClin Infect Dis2014583e44e10024311479
  • BoggildAKCastelliFGautretPGeoSentinel Surveillance NetworkVaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance NetworkVaccine201028467389739520851081
  • MahonBENewtonAEMintzEDEffectiveness of typhoid vaccination in US travelersVaccine201432293577357924837780
  • MacLennanCAMartinLBMicoliFVaccines against invasive disease: current status and future directionsHum Vaccin Immunother20141061478149324804797
  • Centers for Disease Control and Prevention (CDC)Typhoid immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep199443RR1417
  • BegierEMBurwenDRHaberPBallRPostmarketing safety surveillance for typhoid fever vaccines from the vaccine adverse event reporting system, July 1990 through June 2002Clin Infect Dis200438677177914999618
  • MartinLBVaccines for typhoid fever and other salmonellosesCurr Opin Infect Dis201225548949922825288
  • MarcusLCFroeschleJEHillDRSafety of Typhim Vi vaccine in a postmarketing observational studyJ Travel Med200714638639117995534
  • KroonFPvan DisselJTRavensbergenENibberingPHvan FurthRImpaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi)Vaccine19991723–242941294510462227
  • FioreAEWasleyABellBPAdvisory Committeee on Immunization Practices (ACIP)Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep200655RR–712316410759
  • GuntherMStarkKNeuhausRReinkePSchroderKBienzleURapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipientsTransplantation200171347747911233913
  • Centers for Disease Control and Prevention (CDC)Use of Japanese encephalitis vaccine in children: recommendations of the Advisory Committee on Immunization Practices 2013MMWR Morb Mortal Wkly Rep2013624589890024226626
  • GibbonsRVRupprechtCEPostexposure rabies prophylaxis in immunosuppressed patientsJAMA2001285121574157511268256
  • National Center for Immunization and Respiratory DiseasesGeneral recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep2011602164
  • Danziger-IsakovLKumarDAST infectious diseases community of practice. Vaccination in solid organ transplantationAm J Transplant201313suppl 431131723465023
  • LjungmanPAschanJGustafssonBLewensohn-FuchsIWiniarskiJRingdenOLong-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipientsBone Marrow Transplant200434121067106915489876
  • Centers for Disease Control and Prevention (CDC)Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal diseaseMMWR Morb Mortal Wkly Rep200958371042104319779400
  • TomczykSBennettNMStoeckerCCenters for Disease Control and Prevention (CDC)Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep2014633782282525233284
  • Centers for Disease Control and Prevention (CDC)Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Morb Mortal Wkly Rep2012614081681923051612
  • Centers for Disease Control and Prevention (CDC)Increased transmission and outbreaks of measles – European region, 2011MMWR Morb Mortal Wkly Rep201160471605161022129994
  • Merck & CoMeasles, Mumps, and Rubella Virus Vaccine Live2014 Available from: http://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdfAccessed October 1, 2014
  • KottonCNTravel and transplantation: travel-related diseases in transplant recipientsCurr Opin Organ Transplant201217659460023147910
  • JarvisJNLockwoodDNClinical aspects of visceral leishmaniasis in HIV infectionCurr Opin Infect Dis20132611923221770
  • LattesRLasalaMBChagas disease in the immunosuppressed patientClin Microbiol Infect201420430030924602129
  • GonzalezRAtaideRNanicheDMenendezCMayorAHIV and malaria interactions: where do we stand?Expert Rev Anti Infect Ther201210215316522339190
  • WaggonerJJSodaEADeresinskiSRare and emerging viral infections in transplant recipientsClin Infect Dis20135781182118823839998
  • FreedmanDOWeldLHKozarskyPEGeoSentinel Surveillance NetworkSpectrum of disease and relation to place of exposure among ill returned travelersN Engl J Med2006354211913016407507
  • Centers for Disease Control and Prevention (CDC)Chikungunya virus in the United States2014 Available from: http://www.cdc.gov/chikungunya/geo/united-states.htmlAccessed July 22, 2014
  • Centers for Disease Control and Prevention (CDC)Guidelines for Treatment of Malaria in the United States2014 Available from: http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdfAccessed July 22, 2014
  • HillDRBeechingNJTravelers’ diarrheaCurr Opin Infect Dis201023548148720683261
  • TribbleDRSandersJWPangLWTraveler’s diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimenClin Infect Dis200744333834617205438
  • AbubakarIAliyuSHArumugamCHunterPRUsmanNKPrevention and treatment of cryptosporidiosis in immunocompromised patientsCochrane Database Syst Rev20071CD00493217253532
  • PanackalAAHjjehRACetronMSWarnockDWFungal infections among returning travelersClin Infect Dis20023591088109512384843
  • Brett-MajorDMLipnickRJAntibiotic prophylaxis for leptospirosisCochrane Database Syst Rev20093CD00734219588424
  • KottonCNFreedmanDOAdvising Travelers With Specific Needs: Immunocompromised TravelerChapter 8: The Yellow Book2014 Available from: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-8-advising-travelers-with-specific-needs/immunocompromised-travelersAccessed October 2, 2014
  • GershmanMDStaplesJEInfectious Diseases Related to Travel: Yellow FeverChapter 3: Yellow Book2014 Available from: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/yellow-feverAccessed October 1, 2014